[1]
C. Weeks, “Allogeneic Stem Cell Transplantation for High/Ultra High-Risk Multiple Myeloma”, J Hematol, vol. 14, no. 1, pp. 38–42, Feb. 2025, doi: 10.14740/jh1380.